CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 400,000 shares at $19.00 ($7,600,000)
- 3/A Insider 3/A
- 4 Open-market buy Director bought 400,000 shares at $19.00 ($7,600,000)
- 4 Open-market buy 10% owner bought 853,000 shares at $19.00 ($16,207,000)
- 4 Open-market buy 10% owner bought 975,000 shares at $19.00 ($18,525,000)
- 4 Open-market buy Director bought 975,000 shares at $19.00 ($18,525,000)
- 4 Open-market buy Director bought 3,000 shares at $19.00 ($57,000)
- 4 Open-market buy Director bought 850,000 shares at $19.00 ($16,150,000)
- 4 Open-market buy VP Fin & Chief Acct Officer bought 3,000 shares at $19.00 ($57,000)
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at $19.00 ($57,000)
- 4 Conversion Chief Business Officer acquired 10,529 shares (conversion)
- 4 Conversion President and CEO acquired 27,292 shares (conversion)
Page 19 of 22 · 421 filings